hypertension, clinical nephrology
Lois Anne Katz, M.D. has been a coinvestigator in several large VA Cooperative Hypertension Trials: (1) CSP 290 Monotherapy of Hypertension, (2) PATHS - Prevention and Treatment of Hypertension Study (involving behavior modification of patients who drink and have hypertension), (3) ALLHAT - The Antihypertensive and Lipid -lowering Treatment to Prevent Heart Attack Trial sponsored by the NHBLI. She was an investigator in ACCORD--Action to Control Cardiovascular Risk in Diabetes, sponsored by NHLBI. She was a principal investigator for the SPRINT Study and SPRINT-ASK. She has also participated in many pharmaceutical company sponsored trials of new antihypertensive agents including ACE inhibitors, Ca channel blockers, and beta blockers.
She participated in an HSR&D Trial entitled Readiness for Managed Care which was performed in conjunction with Dr. Michael Yedidia at the Wagner School of Public Health.
VA NY Harbor Healthcare System, 423 East 23rd Street
11, 11066 S e
New York, NY 10010
Hypertension. 2019 Jul 01; HYPERTENSIONAHA11912907
Ethnicity & disease. 2019 Nov ; 29(4):567-576
Clinical journal of the American Society of Nephrology : CJASN. 2018 Nov 07; 13(11):1693-1702